Literature DB >> 16181229

SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects.

Annalisa Nicoletti1, Lilia Baldazzi, Antonio Balsamo, Lorella Barp, Piero Pirazzoli, Monia Gennari, Giorgio Radetti, Emanuele Cacciari, Alessandro Cicognani.   

Abstract

OBJECTIVE: The differential diagnosis of male under-masculinization, including a wide spectrum of phenotypes and a heterogeneous genetic basis, is crucial for the correct management of the patients. To characterize an Italian population of under-masculinized males, we performed the molecular analysis of the SRD5A2 gene (2p23), encoding the 5alpha-reductase-2 enzyme that converts testosterone (T) to dihydrotestosterone (DHT), and is required for full masculinization of the male foetus. DESIGN AND PATIENTS: Twenty-six Italian patients with 46,XY kariotype and various degrees of ambiguous genitalia were retrospectively selected for this study. Twelve of these patients, 10 of whom were referred for partial androgen insensitivity syndrome (PAIS), were raised as females; 15 were raised as males and all had a severe hypospadias. For most of the patients, the case histories and hormonal findings were incomplete but all could be included in the clinical characteristics of under-masculinization. MEASUREMENT: For hormonal evaluation, T and DHT were measured by means of radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC)-RIA methods, respectively. Genomic DNA of all patients and relatives was extracted from peripheral blood, the five exons of the SRD5A2 gene were amplified by polymerase chain reaction (PCR) and submitted to automatic sequencing.
RESULTS: Five known mutations affecting the NADPH binding function and one new mutation affecting the enzyme C-terminus were identified in a total of eight patients (two of whom were sisters). Five families were characterized, and in two patients only one affected allele was observed. The extension of the analysis to the regions flanking exons allowed the identification of a new polymorphism in intron 2, whose frequency was determined.
CONCLUSION: This first report of an Italian population underlines the importance of differential diagnoses in patients with under-masculinization. The lack of precise genotype-phenotype correlation in some of the mutations highlights the necessity to improve knowledge about the biochemical aspects of steroid 5alpha-reductase action and about the interactions of genetic and environmental factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181229     DOI: 10.1111/j.1365-2265.2005.02348.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  16 in total

Review 1.  Practical approach to steroid 5alpha-reductase type 2 deficiency.

Authors:  Chong Kun Cheon
Journal:  Eur J Pediatr       Date:  2010-03-28       Impact factor: 3.183

2.  Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population.

Authors:  Meshael M Alswailem; Ohoud S Alzahrani; Lamyaa Alghofaili; Ebtesam Qasem; Mai Almohanaa; Afaf Alsagheir; Bassam Bin Abbas; Najya A Attia; Adnan Al Shaikh; Ali S Alzahrani
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

3.  The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency.

Authors:  N Skordis; V Neocleous; A Kyriakou; E Efstathiou; A Sertedaki; P Philibert; L A Phylactou; S Lumbroso; C Sultan
Journal:  J Endocrinol Invest       Date:  2010-05-28       Impact factor: 4.256

4.  Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia.

Authors:  Felipe Vilchis; Evangelina Valdez; Luis Ramos; Rocio García; Rita Gómez; Bertha Chávez
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

Review 5.  Diagnosis of diseases of steroid hormone production, metabolism and action.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-02

6.  Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency.

Authors:  Nélio Neves Veiga-Junior; Pedro Augusto Rodrigues Medaets; Reginaldo José Petroli; Flávia Leme Calais; Maricilda Palandi de Mello; Carla Cristina Telles de Sousa Castro; Guilherme Guaragna-Filho; Letícia Espósito Sewaybricker; Antonia Paula Marques-de-Faria; Andréa Trevas Maciel-Guerra; Gil Guerra-Junior
Journal:  Int J Endocrinol       Date:  2011-12-12       Impact factor: 3.257

7.  Genetic sequencing of a patient with Kallmann syndrome plus 5α-reductase type 2 deficiency.

Authors:  Wen Ji; Lu-Yao Zhang; Fu-Cheng Li; Yu Wang; Wei He; Qi-Qi Yin; Zhi-Hong Liao
Journal:  Asian J Androl       Date:  2017 May-Jun       Impact factor: 3.285

Review 8.  Similar causes of various reproductive disorders in early life.

Authors:  Konstantin Svechnikov; Jan-Bernd Stukenborg; Iuliia Savchuck; Olle Söder
Journal:  Asian J Androl       Date:  2014 Jan-Feb       Impact factor: 3.285

9.  46,XY disorder of sexual development resulting from a novel monoallelic mutation (p.Ser31Phe) in the steroid 5α-reductase type-2 (SRD5A2) gene.

Authors:  Bertha Chávez; Luis Ramos; Rita Gómez; Felipe Vilchis
Journal:  Mol Genet Genomic Med       Date:  2014-03-16       Impact factor: 2.183

10.  Disorders of sex development: a genetic study of patients in a multidisciplinary clinic.

Authors:  Luigi Laino; Silvia Majore; Nicoletta Preziosi; Barbara Grammatico; Carmelilia De Bernardo; Salvatore Scommegna; Anna Maria Rapone; Giacinto Marrocco; Irene Bottillo; Paola Grammatico
Journal:  Endocr Connect       Date:  2014-09-23       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.